Document Detail


Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease.
MedLine Citation:
PMID:  19114068     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
As one of the earliest pathologic changes, the aberrant re-expression of many cell cycle-related proteins and inappropriate cell cycle control in specific vulnerable neuronal populations in Alzheimer's disease (AD) is emerging as an important component in the pathogenesis leading to AD and other neurodegenerative diseases. These events are clearly representative of a true cell cycle, rather than epiphenomena of other processes since, in AD and other neurodegenerative diseases, there is a true mitotic alteration that leads to DNA replication. While the exact role of cell cycle re-entry is unclear, recent studies using cell culture and animal models strongly support the notion that the dysregulation of cell cycle in neurons leads to the development of AD-related pathology such as hyperphosphorylation of tau and amyloid-beta deposition and ultimately causes neuronal cell death. Importantly, cell cycle re-entry is also evident in mutant amyloid-beta precursor protein and tau transgenic mice and, as in human disease, occurs prior to the development of the pathological hallmarks, neurofibrillary tangles and amyloid-beta plaques. Therefore, the study of aberrant cell cycle regulation in model systems, both cellular and animal, may provide extremely important insights into the pathogenesis of AD and also serve as a means to test novel therapeutic approaches.
Authors:
Hyoung-Gon Lee; Gemma Casadesus; Xiongwei Zhu; Rudy J Castellani; Andrew McShea; George Perry; Robert B Petersen; Vladan Bajic; Mark A Smith
Related Documents :
9823588 - The cell cycle: a review.
6341358 - Cell cycle parameters of slowly growing escherichia coli b/r studied by flow cytometry.
705178 - Biology of the human myeloma cell population. ii. cytokinetic characteristics.
6895218 - Regulation of polypeptide synthesis during caulobacter development: two-dimensional gel...
20618998 - Microrna-221 and microrna-222 regulate gastric carcinoma cell proliferation and radiore...
17660318 - Fluorescence nanoscopy in whole cells by asynchronous localization of photoswitching em...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review     Date:  2008-12-09
Journal Detail:
Title:  Neurochemistry international     Volume:  54     ISSN:  0197-0186     ISO Abbreviation:  Neurochem. Int.     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2009-02-23     Completed Date:  2009-05-01     Revised Date:  2010-12-03    
Medline Journal Info:
Nlm Unique ID:  8006959     Medline TA:  Neurochem Int     Country:  England    
Other Details:
Languages:  eng     Pagination:  84-8     Citation Subset:  IM    
Affiliation:
Department of Pathology, Case Western Reserve University, Cleveland, OH, USA. hyoung-gon.lee@case.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alzheimer Disease / pathology*,  therapy*
Amyloid beta-Peptides / metabolism,  physiology
Cell Cycle / physiology*
Cell Death / physiology
Humans
Nerve Degeneration / pathology*
Oxidative Stress / physiology
Presenilins / metabolism,  physiology
tau Proteins / metabolism,  physiology
Grant Support
ID/Acronym/Agency:
R01 AG028679-01A2/AG/NIA NIH HHS; R21 AG030096-02/AG/NIA NIH HHS; R21 AG031364-02/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Amyloid beta-Peptides; 0/Presenilins; 0/tau Proteins
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of pranoprofen on endoplasmic reticulum stress in the primary cultured glial cells.
Next Document:  Ghrelin alters postnatal endocrine secretion and behavior in mouse offspring.